Wnts regulate important intracellular signaling events, and dysregulation of the Wnt pathway has been linked to human disease. Here, we uncover numerous Wnt canonical effectors in human platelets where Wnts, their receptors, and downstream signaling components have not been previously described. We demonstrate that the Wnt3a ligand inhibits platelet adhesion, activation, dense granule secretion, and aggregation. Wnt3a also altered platelet shape change and inhibited the activation of the small GTPase RhoA. In addition, we found the Wnt--catenin signaling pathway to be functional in platelets. Finally, disruption of the Wnt Frizzled 6 receptor in the mouse resulted in a hyperactivatory platelet phenotype and a reduced sensitivity to Wnt3a. Taken together our studies reveal a novel functional role for Wnt signaling in regulating anucleate platelet function and may provide a tractable target for future antiplatelet therapy.Wnt--catenin pathway ͉ integrin ␣IIb3 ͉ frizzled 6 knockout mice A nucleate platelets are the principle effectors of haemostasis and are found circulating in a nonadhesive, quiescent state. At sites of vascular damage, platelets adhere to various exposed subendothelial matrix proteins and are activated, converting from a resting, discoid shape into larger, flattened structures with extended pseudopodia (1). Such activated platelets secrete and synthesize further agonists, inflammatory mediators, and vasoactive substances and through conformational changes in their major integrin receptor, ␣IIb3, aggregate to other platelets via fibrinogen (Fb) to form a haemostatic plug (2). Aberrant platelet activation can cause pathological thrombus formation, leading to thrombosis and ultimately vessel occlusion and tissue ischemia, the processes underlying myocardial infarction and stroke. Understanding the regulation of platelet activity is thus fundamental to comprehending thrombotic disorders and developing therapeutic strategies.The mammalian Wnt gene family is comprised of 19 secreted Wnt glycoproteins, which play essential roles in cell proliferation, cell-fate determination, and cell-fate differentiation during embryonic development and adult homeostasis (3, 4). These Wnt ligands activate a number of different signaling pathways via distinct receptors and downstream effectors to mediate effects on gene transcription and cell adhesion/migration (5, 6). For the Wnt--catenin (-cat) signaling pathway (Fig. 1A), traditionally referred to as the ''canonical'' pathway, Wnts bind to a surface receptor complex comprised of a Frizzled (Fzd) receptor and the Lipoprotein Receptor-related Protein 5/6 (LRP5/6) coreceptor (5, 7). The signal is then transduced to the cytoplasmic protein Dishevelled (Dvl) where downstream pathways regulate the stability of -cat (5, 7). In the absence of Wnt, -cat is phosphorylated by a destruction complex containing Casein Kinase 1 (CK1), Glycogen Synthase Kinase 3 (GSK3), Axin-1, FRAT-1, and Adenomatous Polyposis Coli (APC), which targets -cat for degradation via ubiquitina...